| The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine. | |
| | |
MedLine Citation:
|
PMID: 22193347 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Heart rate is a major determinant of cardiac output, myocardial oxygen consumption and coronary blood flow under physiological and pathological conditions. Experimental and clinical data have demonstrated that heart rate reduction is the main mechanism for reducing ischemia, improving left ventricular function, decreasing the risk of plaque rupture and post myocardial infarction mortality. Nowadays betablockers are the best class of drugs that can lower heart rate in patients with cardiovascular diseases, but sometimes their use is limited by some contraindications. Ivabradine is a new drug that reduces the firing rate of pacemaker cells in the sinoatrial node through a different mechanism with respect to betablockers. The purpose of this review is to investigate the main trials that support Ivabradine adoption in clinical practice. |
| | |
Authors:
|
E Vizzardi; I Bonadei; A D'Aloia; F Del Magro; B Piovanelli; L Bontempi; A Curnis; L Dei Cas |
Related Documents
:
|
6389067 - The adult respiratory distress syndrome. 21807867 - Combined testing of high-sensitivity troponin t and copeptin on presentation at prespec... 22095727 - Circadian dependence of infarct size and left ventricular function after st elevation m... 2105627 - Determinants of hospital charges for coronary artery bypass surgery: the economic conse... 8404977 - Myocardial fibrosis--a rare complication in patients with cystic fibrosis. 19913457 - The cardiovascular unit as a dynamic player in disease and regeneration. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Minerva medica Volume: 102 ISSN: 0026-4806 ISO Abbreviation: Minerva Med. Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-12-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0400732 Medline TA: Minerva Med Country: Italy |
Other Details:
|
Languages: eng Pagination: 373-9 Citation Subset: IM |
Affiliation:
|
Section of Cardiovascular diseases, Department of Experimental and Applied MedicineUniversity of Study of Brescia, Brescia, Italy - enrico.vizzardi@tin.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diagnostic and prognostic value of alpha-fetoprotein, des-?-carboxy prothrombin and squamous cell ca...
Next Document: Left main coronary artery disease in 2011: CABG or PCI?